Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort descending Project # RFA # PI/Project Leader Institution Title Status
2000 R21 PAR-98-067 MELDRUM, DEIRDRE R. UNIVERSITY OF WASHINGTON AUTOMATED MINIMAL RESIDUAL DISEASE QUANTIFICATION Complete
2002 R21 PAR-99-100 SMITH, LLOYD M UNIVERSITY OF WISCONSIN MADISON SINGLE DROPLET ELECTROSPRAY IONIZATION Complete
2005 R21 RFA-CA-05-002 CHIOCCA, E. ANTONIO OHIO STATE UNIVERSITY IMAGING TRANSCRIPTIONAL ACTIVATION OF GLIOMAS Complete
2008 R21 RFA-CA-07-033 REHEMTULLA, ALNAWAZ UNIVERSITY OF MICHIGAN HTS FOR FADD KINASE INHIBITORS USING MOLECULAR IMAGING Complete
2011 R21 RFA-CA-10-003 BIEBERICH, CHARLES J. UNIVERSITY OF MARYLAND BALT CO CAMPUS APPLICATION OF AN INNOVATIVE TECHNOLOGY TO DEVELOP LOW TOXICITY KINASE INHIBITORS Complete
2015 R21 RFA-CA-14-003 LABAER, JOSHUA ARIZONA STATE UNIVERSITY-TEMPE CAMPUS MULTIPLEXED IN SOLUTION PROTEIN ARRAY (MISPA) FOR IDENTIFYING NOVEL PROTEIN INTERACTIONS IN CANCER AND FOR EARLY DETECTION OF IMMUNE RESPONSES IN PATHOGEN-INDUCED CANCERS Complete
2018 R21 RFA-CA-17-010 SHI, TUJIN BATTELLE PACIFIC NORTHWEST LABORATORIES An ultrasensitive targeted mass spectrometry system for proteomics analysis of single cells Active
2004 R21 PAR-01-106 SCHROEDER, JANE CLOWNEY UNIVERSITY OF NORTH CAROLINA CHAPEL HILL EPIDEMIOLOGY OF ATYPICAL EPSTEIN-BARR VIRUS IN LYMPHOMA Complete
2007 R21 RFA-CA-07-017 XU, BAOGANG JONATHAN VANDERBILT UNIVERSITY MED CTR IDENTIFICATION OF BREAST TUMOR SECRETOME CHANGES THROUGHOUT TUMOR PROGRESSION Complete
2010 R21 RFA-CA-09-008 RIETHMAN, HAROLD WISTAR INSTITUTE TECHNOLOGY FOR DETECTION AND QUANTITATION OF TELOMERIC DNA ABERRATIONS IN CANCER Complete
2014 R21 RFA-CA-13-001 CHEN, XIAOWEI RESEARCH INST OF FOX CHASE CAN CTR A NOVEL ALLELE-SPECIFIC RNA-ISH FOR DIFFERENTIAL ALLELE-SPECIFIC EXPRESSION Complete
2017 R21 RFA-CA-16-001 SLATER, JOHN HUNDLEY UNIVERSITY OF DELAWARE A Vascularized, In Vitro, Organotropic Metastasis Model to Generate Dormant Micrometastases NCE
2001 R21 PAR-99-100 LIEBER, CHARLES M HARVARD UNIVERSITY CARBON NANOTUBE PROBES FOR DIRECT DNA SEQUENCE ANALYSIS Complete
2020 R33 RFA-CA-19-020 CHEN, FEI BROAD INSTITUTE, INC. Clinical implementations of spatial transcriptomics in tumors Active
2000 R33 PAR-99-100 JARVIK, JONATHAN W CARNEGIE-MELLON UNIVERSITY TECHNOLOGIES FOR COMPREHENSIVE FUNCTIONAL PROTEOMICS Complete
2002 R33 PAR-99-102 SPEICHER, DAVID W. WISTAR INSTITUTE NOVEL COMPREHENSIVE PROTEOME ANALYSES OF METASTASIS Complete
1999 R33 PAR-98-067 RAMSEY, JOHN MICHAEL LOCKHEED MARTIN ENERGY RESEARCH CORP DEVICES FOR HIGH THROUGHPUT CELLULAR PROTEIN ANALYSIS Complete
2001 R33 PAR-99-102 BROCK, GRAHAM J UNIVERSITY OF GLASGOW IDENTIFICATION OF M5CPG ALTERATIONS IN BREAST CARCINOMAS Complete
2004 R33 PAR-01-104 O'LEARY, TIMOTHY J. AMERICAN REGISTRY OF PATHOLOGY, INC. RECOVERY OF PROTEIN FROM FORMALIN-FIXED TISSUES Complete
2003 R33 PAR-01-104 ARAP, WADIH UNIVERSITY OF TEXAS MD ANDERSON CAN CTR STEM CELL-BRAIN TUMOR INTERPLAY & IN VIVO PHAGE DISPLAY Complete
2016 R33 RFA-CA-15-005 AKSAN, ALPTEKIN UNIVERSITY OF MINNESOTA VALIDATION OF A ROOM-TEMPERATURE STORAGE TECHNIQUE FOR PLASMA/SERUM BIOSPECIMENS NCE
2020 R33 RFA-CA-19-020 FAN, RONG YALE UNIVERSITY High-throughput single-cell co-sequencing of small and large RNAs to identify molecular circuitry in cancer Active
2000 R33 PAR-99-100 LAM, KIT S UNIVERSITY OF CALIFORNIA DAVIS LIGANDS FOR ALTERED PHOSPHOPROTEINS IN CANCER Complete
1999 R33 PAR-98-067 YATES, JOHN ROBERT UNIVERSITY OF WASHINGTON DIRECT MS ANALYSIS OF COMPLEX PROTEIN MIXTURES Complete
2001 R33 PAR-99-102 GALE, JAMES M UNIVERSITY OF NEW MEXICO MOLECULAR STAGING OF HUMAN SQUAMOUS CELL SKIN CANCER Complete
2004 R33 PAR-01-104 MUDDIMAN, DAVID C. MAYO CLINIC OVARIAN CANCER SCREENING USING COMPREHENSIVE PROTEOMICS Complete
2003 R33 PAR-01-104 TAYLOR, CLIVE R UNIVERSITY OF SOUTHERN CALIFORNIA RETRIEVAL OF DNA, RNA, AND PROTEIN FROM ARCHIVAL TISSUE Complete
2016 R33 RFA-CA-15-005 JOHANN, DONALD UNIV OF ARKANSAS FOR MED SCIS DEVELOPMENT AND VALIDATION OF A MICRODISSECTION METHOD TO ADVANCE PRECISION MEDICINE IN THE CLINICAL SETTING NCE
2000 R33 PAR-99-100 WIGLER, MICHAEL H COLD SPRING HARBOR LABORATORY HIGH DENSITY GENE COPY NUMBER MICROARRAYS Complete
2018 R33 RFA-CA-17-011 BROWN, BRIAN D ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Pro-Codes: A novel vector and cell barcoding technology Active
2004 R33 PAR-01-106 VIDAL, MARC DANA-FARBER CANCER INSTITUTE INTEGRATED INTERACTOME MAPPING Complete
2003 R33 PAR-01-104 LAM, KIT S UNIVERSITY OF CALIFORNIA DAVIS SMALL MOLECULE MICROARRAYS FOR INTRACELLULAR PROTEINS Complete
2016 R33 RFA-CA-15-005 SOKER, SHAY WAKE FOREST UNIVERSITY HEALTH SCIENCES BIOENGINEERED LUNG TUMOR ORGANOIDS FOR DEVELOPMENT OF PERSONALIZED MEDICINE Complete
2020 R33 RFA-CA-19-022 HASHAM, MUNEER GULAMHUSEIN JACKSON LABORATORY Impact of Genetic Diversity on Human Xenograft Tumor Growth Active
2000 R33 PAR-99-100 CONTAG, CHRISTOPHER H STANFORD UNIVERSITY VISIBLE ANIMAL MODELS OF NEOPLASTIC DISEASE Complete
2018 R33 RFA-CA-17-011 CHENG, JI-XIN BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level Active
2004 R33 PAR-01-106 ZANGAR, RICHARD C BATTELLE PACIFIC NORTHWEST LABORATORIES PROTEOMIC IDENTIFICATION OF NAF BIOMARKERS Complete
2017 R33 RFA-CA-16-002 LEVENSON, RICHARD M. UNIVERSITY OF CALIFORNIA AT DAVIS Cancer histology and QC via MUSE: Sample-sparing UV surface-excitation microscopy NCE
2003 R33 PAR-01-106 FURGE, KYLE A VAN ANDEL RESEARCH INSTITUTE COMPARATIVE GENOMIC ANALYSIS OF MICROARRAY DATA Complete
2000 R33 PAR-99-102 POOLA, INDIRA NONE HOWARD UNIVERSITY MOLECULAR ASSAY FOR ESTROGEN RECEPTORS IN BREAST TUMORS Complete
2018 R33 RFA-CA-17-011 CIMA, MICHAEL J MASSACHUSETTS INSTITUTE OF TECHNOLOGY Advanced development and validation of microdevices for high-throughput in situ drug sensitivity testing in tumors Active
2004 R33 PAR-01-106 SINGER, ROBERT H ALBERT EINSTEIN COL OF MED YESHIVA UNIV FISH AND CHIPS: SINGLE CELL EXPRESSION OF CANCER GENES Complete
2007 R33 RFA-CA-07-001 MILOSAVLJEVIC, ALEKSANDAR BAYLOR COLLEGE OF MEDICINE MULTIPLEXED METHODS FOR THE STUDY OF CHROMOSOMAL ABERRATIONS IN CANCER Complete
2017 R33 RFA-CA-16-002 KELLEY, SHANA O UNIVERSITY OF TORONTO Development and validation of nanoparticle-mediated microfluidic profiling approach for rare cell analysis NCE
2001 R33 PAR-98-067 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON HIGH THROUGHPUT CALI FOR TARGET VALIDATION IN METASTASIS Complete
2003 R33 PAR-01-106 COLLINS, COLIN C UNIVERSITY OF CALIFORNIA SAN FRANCISCO DEVELOPMENT OF ESP: STRUCTURAL & FUNCTIONAL ONCOGENOMICS Complete
2013 R33 RFA-CA-12-003 JI, HANLEE P STANFORD UNIVERSITY OLIGONUCLEOTIDE-SELECTIVE SEQUENCING FOR INTEGRATED AND RAPID CANCER GENOME ANALY Complete
2018 R33 RFA-CA-17-011 JIANG, NING UNIVERSITY OF TEXAS, AUSTIN An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer Active
2007 R33 RFA-CA-07-001 ROTHSTEIN, RODNEY J. COLUMBIA UNIVERSITY HEALTH SCIENCES USING SYNTHETIC DOSAGE LETHALITY TO SCREEN FOR NOVEL ANTI-TUMOR TARGETS Complete
2017 R33 RFA-CA-16-002 WANG, YINGXIAO UNIVERSITY OF CALIFORNIA, SAN DIEGO Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells Active

Pages